retatrutide fda approval status 2024 What Are the New Weight Loss Medications? Retatrutide produces up to 30.3%

The mechanisms of these effects are largely unknown

In recent years, there has been an increasing body of evidence to suggest that GLP-1s are an effective treatment as a weight-loss medication

Microdosing GLP-1 is often discussed as a way to ease into therapy more slowly, giving the body time to adapt to appetite and gastrointestinal changes

If either applies, consulting a healthcare provider makes sense

Working with a qualified provider ensures monitoring for muscle loss and implementation of strategies to preserve lean tissue during treatment

The mechanisms underlying the favorable cardiovascular effects of GLP-1RAs remain incompletely understood